申请人:The Scripps Research Institute
公开号:US20210196713A1
公开(公告)日:2021-07-01
The present disclosure provides compounds, their pharmaceutical compositions, and methods of their use for treating mesenchymally-derived or mesenchymally transformed cancers, such as breast cancers and sarcomas, and for treating diseases or disorders that are characterized by the expression of vimentin.